Brooke N. Bullock, Ph.D. - Publications
Affiliations: | 2014 | Chemistry | New York University, New York, NY, United States |
Area:
Bioorganic ChemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Xie X, Piao L, Bullock BN, Smith A, Su T, Zhang M, Teknos TN, Arora PS, Pan Q. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma. Oncogene. 33: 1037-46. PMID 23474763 DOI: 10.1038/Onc.2013.25 | 0.539 | |||
2013 | Drew K, Renfrew PD, Craven TW, Butterfoss GL, Chou FC, Lyskov S, Bullock BN, Watkins A, Labonte JW, Pacella M, Kilambi KP, Leaver-Fay A, Kuhlman B, Gray JJ, Bradley P, et al. Adding diverse noncanonical backbones to rosetta: enabling peptidomimetic design. Plos One. 8: e67051. PMID 23869206 DOI: 10.1371/Journal.Pone.0067051 | 0.659 | |||
2013 | Raj M, Bullock BN, Arora PS. Plucking the high hanging fruit: a systematic approach for targeting protein-protein interactions. Bioorganic & Medicinal Chemistry. 21: 4051-7. PMID 23267671 DOI: 10.1016/J.Bmc.2012.11.023 | 0.712 | |||
2012 | Kushal S, Bullock B, Henchey L, Arora P, Olenyuk B. Abstract 289: Hydrogen bond surrogate (HBS) helices as orthosteric regulator of hypoxia inducible transcription Cancer Research. 72: 289-289. DOI: 10.1158/1538-7445.Am2012-289 | 0.588 | |||
2012 | Grishagin IV, Olenyuk BZ, Bullock B, Arora PS. Abstract 283: OOPs: Novel HIF-1α mimics Cancer Research. 72: 283-283. DOI: 10.1158/1538-7445.Am2012-283 | 0.639 | |||
2011 | Bullock BN, Jochim AL, Arora PS. Assessing helical protein interfaces for inhibitor design. Journal of the American Chemical Society. 133: 14220-3. PMID 21846146 DOI: 10.1021/Ja206074J | 0.61 | |||
2011 | Guarracino DA, Bullock BN, Arora PS. Mini review: protein-protein interactions in transcription: a fertile ground for helix mimetics. Biopolymers. 95: 1-7. PMID 20882600 DOI: 10.1002/Bip.21546 | 0.721 | |||
Show low-probability matches. |